SEO URLwww.firestrike.ai/deals/surf-bio-halozyme-therapeutics-acquisition-2026-1
acquisitionAnnounced · Jan 28, 2026Chemical Manufacturing (325)Source · CredibleArticle · Factual
Halozyme Therapeutics acquires Surf Bio
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$400M
Target
Surf Bio
Palo Alto, California
Acquirer
Halozyme Therapeutics
Full Acquisition
Status
Completed
Halozyme Therapeutics agreed to acquire Surf Bio. Reported deal value: $400M. Status: Completed. Sector: Not specified. Target headquarters context: Palo Alto, California, United States.
This page summarizes publicly available information about the transaction as of 2026-01-28. Figures and status may change as filings and press coverage update.
Halozyme Therapeutics , Inc. acquired Surf Bio , Inc. for $ 400 million in December 2025
Deal timeline
Announced
Jan 28, 2026 · marketscreener.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Chemical Manufacturing (325) with a reported deal value of $400M. Figures and status may change as sources update.
Sources: marketscreener.com · Primary article · FireStrike proprietary index